Anne Michel,Patrick Downey,Florian Montel,Dieter Scheller,Bernard Christophe
申请号：
US14395533
公开号：
US20150157638A1
申请日:
2013.04.19
申请国别(地区):
US
年份:
2015
代理人:
摘要：
The invention pertains to a method of treating Parkinson's disease (PD) in a mammal, comprising administering a first pharmaceutical agent and a second pharmaceutical agent, wherein the first pharmaceutical agent is an antagonist of the adenosine receptor 2 (A2A) and the second pharmaceutical agent is an antagonist of the N-methyl-D-aspartate (NMDA) receptor subtype NR2B.
